CD133+stem and/or progenitor-like cells characterize the lymphovascular emboli of inflammatory breast carcinoma

被引：0
|
作者：
Yi, XA [1 ]
Barsky, SH [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
FASEB JOURNAL | 2006年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1327 / A1327
页数：1
相关论文
共 50 条
  • [41] The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype
    Xiao, Yi
    Ye, Yin
    Yearsley, Kurtis
    Jones, Susie
    Barsky, Sanford H.
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (02): : 561 - 574
  • [42] Immunotoxin targeting CD133+ breast carcinoma cells
    Ohlfest, John R.
    Zellmer, David M.
    Panyam, Jayanth
    Swaminathan, Suresh Kumar
    Oh, Seunguk
    Waldron, Nate N.
    Toma, Shoko
    Vallera, Daniel A.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2013, 3 (02) : 195 - 204
  • [43] Association between ALDH1+/CD133+stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma
    Lv, Xinquan
    Wang, Yingzi
    Song, Yimin
    Pang, Xia
    Li, Huixiang
    ONCOLOGY LETTERS, 2016, 11 (03) : 1750 - 1756
  • [44] Immunotoxin targeting CD133+ breast carcinoma cells
    John R. Ohlfest
    David M. Zellmer
    Jayanth Panyam
    Suresh Kumar Swaminathan
    Seunguk Oh
    Nate N. Waldron
    Shoko Toma
    Daniel A. Vallera
    Drug Delivery and Translational Research, 2013, 3 : 195 - 204
  • [45] In Vitro Propagation and Characterization of Neoplastic Stem/Progenitor-Like Cells From Human Prostate Cancer Tissue
    Guzman-Ramirez, Natalia
    Voller, Maureen
    Wetterwald, Antoinette
    Germann, Markus
    Cross, Neil A.
    Rentsch, Cyrill A.
    Schalken, Jack
    Thalmann, George N.
    Cecchini, Marco G.
    PROSTATE, 2009, 69 (15): : 1683 - 1693
  • [46] Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma
    YANG Jingpu
    LIU Yan
    ZHONG Wei
    YU Dan
    WEN Lianji
    JIN Chunshun
    中华医学杂志（英文版）, 2011, (07) : 1055 - 1060
  • [47] Ex-vivo expansion of multipotent CD133+stem cells with VEGF, FLT3l and SCGF
    Loges, S
    Butzal, M
    Fischer, U
    Gehling, UM
    Hossfeld, DK
    Fiedler, W
    BLOOD, 2004, 104 (11) : 123B - 124B
  • [48] Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma
    Yang Jing-pu
    Liu Yan
    Zhong Wei
    Yu Dan
    Wen Lian-ji
    Jin Chun-shun
    CHINESE MEDICAL JOURNAL, 2011, 124 (07) : 1055 - 1060
  • [49] Lymphovascular Breast Carcinoma Tumoral Emboli Form through Stem Cell Initiated Self-Budding Histogenesis.
    Barsky, S. H.
    Ye, Y.
    Tellez, J. D.
    Belcher, M.
    Robertson, F. M.
    MODERN PATHOLOGY, 2011, 24 : 27A - 27A
  • [50] Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+stem cells
    Meregalli, Mirella
    Navarro, Claire
    Sitzia, Clementina
    Farini, Andrea
    Montani, Erica
    Wein, Nicolas
    Razini, Paola
    Beley, Cyriaque
    Cassinelli, Letizia
    Parolini, Daniele
    Belicchi, Marzia
    Parazzoli, Dario
    Garcia, Luis
    Torrente, Yvan
    FEBS JOURNAL, 2013, 280 (23) : 6045 - 6060
12345